Literature DB >> 20858421

Lipid polymorphism induced by surfactant peptide SP-B(1-25).

R Suzanne Farver1, Frank D Mills, Vijay C Antharam, Janetricks N Chebukati, Gail E Fanucci, Joanna R Long.   

Abstract

Pulmonary surfactant protein B (SP-B) is an essential protein for lowering surface tension in the alveoli. SP-B(1-25), a peptide comprised of the N-terminal 25 amino-acid residues of SP-B, is known to retain much of the biological activity of SP-B. Circular dichroism has shown that when SP-B(1-25) interacts with negatively charged lipid vesicles, it contains significant helical structure for the lipid compositions and peptide/lipid ratios studied here. The effect of SP-B(1-25) on lipid organization and polymorphisms was investigated via DSC, dynamic light scattering, transmission electron microscopy, and solid-state NMR spectroscopy. At 1-3 mol% peptide and physiologic temperature, SP-B(1-25) partitions at the interface of negatively charged PC/PG lipid bilayers. In lipid mixtures containing 1-5 mol% peptide, the structure of SP-B(1-25) remains constant, but (2)H and (31)P NMR spectra show the presence of an isotropic lipid phase in exchange with the lamellar phase below the T(m) of the lipids. This behavior is observed for both DPPC/POPG and POPC/POPG lipid mixtures as well as for both the PC and PG components of the mixtures. For 1-3 mol% SP-B(1-25), a return to a single lamellar phase above the lipid mixture T(m) is observed, but for 5 mol% SP-B(1-25) a significant isotropic component is observed at physiologic temperatures for DPPC and exchange broadening is observed in (2)H and (31)P NMR spectra of the other lipid components in the two mixtures. DLS and TEM rule out the formation of micellar structures and suggest that SP-B(1-25) promotes the formation of a fluid isotropic phase. The ability of SP-B(1-25) to fuse lipid lamellae via this mechanism, particularly those enriched in DPPC, suggests a specific role for the highly conserved N-terminus of SP-B in the packing of lipid lamellae into surfactant lamellar bodies or in stabilizing multilayer structures at the air-liquid interface. Importantly, this behavior has not been seen for the other SP-B fragments of SP-B(8-25) and SP-B(59-80), indicating a critical role for the proline rich first seven amino acids in this protein.
Copyright © 2010 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858421      PMCID: PMC2941028          DOI: 10.1016/j.bpj.2010.06.076

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  56 in total

Review 1.  Hydrophobic surfactant proteins in lung function and disease.

Authors:  Jeffrey A Whitsett; Timothy E Weaver
Journal:  N Engl J Med       Date:  2002-12-26       Impact factor: 91.245

2.  Surfactant protein profile of pulmonary surfactant in premature infants.

Authors:  Philip L Ballard; Jeffrey D Merrill; Rodolfo I Godinez; Marye H Godinez; William E Truog; Roberta A Ballard
Journal:  Am J Respir Crit Care Med       Date:  2003-08-06       Impact factor: 21.405

Review 3.  Surfactant protein B and C analogues.

Authors:  F J Walther; L M Gordon; J A Zasadzinski; M A Sherman; A J Waring
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

4.  Multilayer formation upon compression of surfactant monolayers depends on protein concentration as well as lipid composition. An atomic force microscopy study.

Authors:  Robert V Diemel; Margot M E Snel; Alan J Waring; Frans J Walther; Lambert M G van Golde; Günther Putz; Henk P Haagsman; Joseph J Batenburg
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

5.  Raman spectra and vibrational assignments for deuterated membrane lipids. 1,2-Dipalmitoyl phosphatidylcholine-d9 and -d62.

Authors:  M R Bunow; I W Levin
Journal:  Biochim Biophys Acta       Date:  1977-11-24

6.  Perturbation of DPPC bilayers by high concentrations of pulmonary surfactant protein SP-B.

Authors:  Michael R Morrow; June Stewart; Svetla Taneva; Awel Dico; Kevin M W Keough
Journal:  Eur Biophys J       Date:  2003-09-23       Impact factor: 1.733

7.  Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37.

Authors:  Katherine A Henzler-Wildman; Gary V Martinez; Michael F Brown; A Ramamoorthy
Journal:  Biochemistry       Date:  2004-07-06       Impact factor: 3.162

8.  Effect of variations in the structure of a polyleucine-based alpha-helical transmembrane peptide on its interaction with phosphatidylcholine bilayers.

Authors:  Feng Liu; Ruthven N A H Lewis; Robert S Hodges; Ronald N McElhaney
Journal:  Biochemistry       Date:  2002-07-23       Impact factor: 3.162

Review 9.  Lipid polymorphism and the functional roles of lipids in biological membranes.

Authors:  P R Cullis; B de Kruijff
Journal:  Biochim Biophys Acta       Date:  1979-12-20

10.  Structure and orientation of pardaxin determined by NMR experiments in model membranes.

Authors:  Fernando Porcelli; Bethany Buck; Dong-Kuk Lee; Kevin J Hallock; Ayyalusamy Ramamoorthy; Gianluigi Veglia
Journal:  J Biol Chem       Date:  2004-07-29       Impact factor: 5.157

View more
  7 in total

1.  Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids.

Authors:  R Duncan Hite; Bonnie L Grier; B Moseley Waite; Ruud A Veldhuizen; Fred Possmayer; Li-Juan Yao; Michael C Seeds
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-10-28       Impact factor: 5.464

2.  Differential effects of the hydrophobic surfactant proteins on the formation of inverse bicontinuous cubic phases.

Authors:  Mariya Chavarha; Ryan W Loney; Kamlesh Kumar; Shankar B Rananavare; Stephen B Hall
Journal:  Langmuir       Date:  2012-11-20       Impact factor: 3.882

3.  Effects of the lung surfactant protein B construct Mini-B on lipid bilayer order and topography.

Authors:  Dharamaraju Palleboina; Alan J Waring; Robert H Notter; Valerie Booth; Michael Morrow
Journal:  Eur Biophys J       Date:  2012-08-19       Impact factor: 1.733

4.  Role of the N-terminal seven residues of surfactant protein B (SP-B).

Authors:  Mahzad Sharifahmadian; Muzaddid Sarker; Dharamaraju Palleboina; Alan J Waring; Frans J Walther; Michael R Morrow; Valerie Booth
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

5.  Lung Surfactant Decreases Biochemical Alterations and Oxidative Stress Induced by a Sub-Toxic Concentration of Carbon Nanoparticles in Alveolar Epithelial and Microglial Cells.

Authors:  Giuseppe Caruso; Claudia G Fresta; Angelita Costantino; Giacomo Lazzarino; Angela M Amorini; Giuseppe Lazzarino; Barbara Tavazzi; Susan M Lunte; Prajnaparamita Dhar; Massimo Gulisano; Filippo Caraci
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 5.923

6.  Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.

Authors:  Roberta L Keller; Jeffrey D Merrill; Dennis M Black; Robin H Steinhorn; Eric C Eichenwald; David J Durand; Rita M Ryan; William E Truog; Sherry E Courtney; Philip L Ballard; Roberta A Ballard
Journal:  Pediatr Res       Date:  2012-10-04       Impact factor: 3.756

7.  Dynamic Nuclear Polarization of Biomembrane Assemblies.

Authors:  Nhi T Tran; Frédéric Mentink-Vigier; Joanna R Long
Journal:  Biomolecules       Date:  2020-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.